Your browser doesn't support javascript.
loading
The costs of heparin-induced thrombocytopenia: a patient-based cost of illness analysis.
Wilke, T; Tesch, S; Scholz, A; Kohlmann, T; Greinacher, A.
Affiliation
  • Wilke T; Institut für Pharmakoökonomie und Arzneimittellogistik, Hochschule Wismar, Wismar, Germany.
J Thromb Haemost ; 7(5): 766-73, 2009 May.
Article in En | MEDLINE | ID: mdl-19220728
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Heparin / Cost of Illness Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2009 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Heparin / Cost of Illness Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2009 Document type: Article Affiliation country: Germany Country of publication: United kingdom